Cleveland Clinic Taussig Cancer Institute
Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.
2019 ASH Review of Frontline CLL: Is There a Role for FCR in 2020 and for Which Pts? Does E1912 Suggest Ibrutinib Can Be Considered a Time Limited Therapy?
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Anthony R. Mato
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Anthony R. Mato
Comments 0
Login to view comments.
Click here to Login
